128
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Combination Therapy with Transdermal Buprenorphine and Pregabalin for Chronic Low Back Pain

, , , , , & show all
Pages 23-31 | Published online: 21 Dec 2011

References

  • Koes BW , van Tulder MW, Thomas S. Diagnosis and treatment of low back pain. BMJ332 , 1430–1434 (2006).
  • Risi G . [Low back pain – from work incapacity to disability.] Ther. Umsch.64(8) , 409–413 (2007).
  • Aronoff GM , EvansWO, EndersPL. A review of follow-up studies of multidisciplinary pain units. Pain16(1) , 1–11 (1983).
  • Wipf JE , DeyoRA. Low back pain. Med. Clin. North Am.79 , 231–246 (1995).
  • Deyo RA , RainvilleJ, KentDL. What can the history and physical examination tell us about low back pain? JAMA268 , 760–765 (1992).
  • Schäfer A , HallT, BriffaK. Classification of low back-related leg pain – a proposed patho-mechanism-based approach. Man. Ther.14(2) , 222–230 (2009).
  • Baron R , BinderA. [How neuropathic is sciatica? The mixed pain concept.] Orthopade33(5) , 568–575 (2004).
  • Devor M , RappaportZH. Pain and the pathophysiology of damaged nerve. In: Pain Syndromes in Neurology. Fields HL (Ed.). Butterworths, London, UK, 47–83 (1990).
  • Woolf CJ , MannionRJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet353(9168) , 1959–1964 (1999).
  • Besson JM , ChaouchA. Peripheral and spinal mechanisms of nociception. Physiol. Rev.67(1) , 67–186 (1987).
  • Bridges D , ThompsonSW, RiceAS. Mechanisms of neuropathic pain. Br. J. Anaesth.87(1) , 12–26 (2001).
  • Aurilio C , PotaV, PaceMC, PassavantiMB, BarbarisiM. Ionic channels and neuropathic pain: physiopathology and applications. J. Cell. Physiol.215(1) , 8–14 (2008).
  • Chou R , Huffman LH; American Pain Society; American College of Physicians. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann. Intern. Med.147(7) , 505–514 (2007).
  • Morlion B . Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components. Curr. Med. Res. Opin.27(1) , 11–33 (2011).
  • Horga de la Parte JF , HorgaA. Pregabalin: new therapeutic contributions of calcium channel α2δ protein ligands on epilepsy and neuropathic pain. Rev. Neurol.42(4) , 223–237 (2006).
  • Pergolizzi J , AloisiAM, DahanA et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract. 10(5) , 428–450 (2010).
  • Aurilio C , PaceMC, PassavantiMB et al. Treatment of ischemic pain in patients suffering from peripheral vasculopathy with transdermal buprenorphine plus epidural morphine with ropivacaine vs. epidural morphine with ropivacaine. Pain Pract. 9(2) , 105–114 (2009).
  • Pace MC , PassavantiMB, GrellaE et al. Buprenorphine in long-term control of chronic pain in cancer patients. Front. Biosci. 12 , 1291–1299 (2007).
  • Camba MA ; The Opioid Study Group of the Spanish Pain Society. Transdermal buprenorphine for the management of nociceptive chronic pain. Rev. Soc. Esp. Dolor.11(Suppl. V) , 22–30 (2004).
  • Likar R , LorenzV, Korak-LeiterM, KagerI, SittlR. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. Clin. Ther.29(8) , 1591–1606 (2007).
  • Martell BA , O‘ConnorPG, KernsRD et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann. Intern. Med. 146(2) , 116–127 (2007).
  • Forde G . Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profiles. J. Fam. Pract.56(2 Suppl. Pain) , 3–12 (2007).
  • de Leon–Casasola O . New developments in the treatment algorithm for peripheral neuropathic pain. Pain Med.12(Suppl. 3) , S100–S108 (2011).
  • Sittl R , NuijtenM, NautrupBP. Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in Germany. Clin. Ther.28(8) , 1144–1154 (2006).
  • Jadad AR , CarrollD, GlynnCJ, MooreRA, McQuayHJ. Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia. Lancet339(8806) , 1367–1371 (1992).
  • Noble M , SchoellesK. Opioid treatment for chronic back pain and its association with addiction. Ann. Intern. Med.147(5) , 348–349 (2007); author reply 349–350 (2007).
  • Negrini S , GiovannoniS, MinozziS et al. Diagnostic therapeutic flow-charts for low back pain patients: the Italian clinical guidelines. Eura Medicophys. 42(2) , 151–170 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.